Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

NCT02077933

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Memorial Sloan Kettering Cancer Center SC - BYL719Z2102 New York, United States
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Bordeaux, France
View all 22 locations
View Trial Details
Completed

A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)

NCT01235962

Conditions
Adenocarcinoma, Cancer, Carcinoma, +15 more
Locations
  • Novartis Investigative Site Jonesboro, Arkansas, United States
  • Novartis Investigative Site Antioch, California, United States
  • Novartis Investigative Site Beverly Hills, California, United States
  • Novartis Investigative Site Fresno, California, United States
View all 312 locations
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Sunitinib in Renal Cell Carcinoma Progressed to 1L Immunotherapy Treatment.

NCT03066427

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • ICO Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
  • Hospital Clínic i Provincial de Barcelona Barcelona, Spain
  • Complejo Hospitalario Regional Reina Sofía Córdoba, Spain
View Trial Details
Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

NCT03538028

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +105 more
Locations
  • The Angeles Clinic and Research Center Los Angeles, California, United States
  • Hackensack Medical Center Hackensack, New Jersey, United States
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

A Biomarker Study of Tivozanib in Subjects With Advanced Renal Cell Carcinoma

NCT01297244

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • Providence Health and Services Burbank, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
View all 25 locations
View Trial Details
Completed

TroVax Renal Immunotherapy Survival Trial

NCT00397345

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • AZ Cancer Center Tucson, Arizona, United States
  • Little Rock Hematology / Oncology Associates, P.A. Little Rock, Arkansas, United States
  • La Jolla, CA La Jolla, California, United States
  • The Angeles Clinic and Reseach Institute Los Angeles, California, United States
View all 152 locations
View Trial Details

Related conditions